Fennec Pharmaceuticals Reports 78% Revenue Jump as Pedmark Demand Reaches Record High
Fennec's Pedmark is reportedly in demand as the only FDA-approved therapy to reduce cisplatin-induced hearing loss in pediatric patients.
Fennec's Pedmark is reportedly in demand as the only FDA-approved therapy to reduce cisplatin-induced hearing loss in pediatric patients.
iClever has introduced the Q950, a children's headphone that has earned TÜV Rheinland Hearing Care Certification — an evaluation spanning safe listening, acoustic performance, adaptive audio care, and active hearing care.
In a pivotal trial, 42% of participants achieved normal hearing using the gene therapy indicated for pediatric and adult patients with severe-to-profound hearing loss due to biallelic OTOF gene variants.
Hearing care professionals can provide more comprehensive patient support and expand practice revenue by offering guidance on hearing technologies, ancillary products, and emerging treatment options beyond traditional hearing aids.
Frank Lin, MD, PhD, discusses the Know Your Hearing Number campaign and why this concept can help break down barriers to hearing care.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.